high selectivity for nicotinergic receptors in insects, where they act as an agonist of the postsynaptic acetylcholine receptor (Matsuda et al., 2001) . Among the most commonly used neonicotinoids are imidacloprid, thiacloprid and thiamethoxam (Jeschke et al., 2010) .
Neonicotinoids have been associated with Colony Collapse Disorder of honey bees (Girolami et al., 2009; Henry et al., 2012) . Neonicotinoids are systemic insecticides, which means they are soluble in water and absorbed by the tissues of the plant, and bees can be exposed to these chemicals through nectar and pollen (Rortais et al., 2005) . An exposure to a non-acutely lethal dose of thiamethoxam and imidacloprid causes a delayed onset of increased mortality in honey bees (Henry et al., 2012) and a decrease in their foraging activity (Decourtye et al., 2004) . Neonicotinoids are also toxic to birds and mammals. For example, imidacloprid (2 and 8 mg/kg/day) adversely affects the reproductive system of male rats, by inducing DNA fragmentation, antioxidant imbalance and apoptosis (Bal et al., 2012) . Moreover, epididymal weight and sperm concentration were lower in imidacloprid exposed rats (Bal et al., 2012 ). An exposure of female rats to imidacloprid (20 mg/kg/day) caused a decrease in ovarian weight, induced changes in granulosa cells of follicles (cytoplasmic clumping, lipofuscin accumulation) and altered levels of luteinizing and follicle stimulating hormones and progesterone (Kapoor et al., 2011) . Daily oral administration of the neonicotinoid clothianidin to female quails caused abnormal ovarian histology of the granulosa cells and a decrease in glutathione peroxidase 4 and manganese superoxide dismutase, two enzymes that protect against oxidative stress (Hoshi et al., 2014) . Furthermore, a 30-day exposure to thiacloprid (112.5 mg/kg) increased the serum levels of free thyroxine and triiodothyronine in rats (Sekeroglu et al., 2014) , demonstrating the endocrine disrupting potential of this class of pesticides. Given these observations and the increasing use of neonicotinoids, a much better understanding of their potential effects on human health is needed.
In North America, breast cancer represents a third of all female cancer diagnoses (WHO/UNEP, 2013) and 70 % of breast cancers are estrogen-dependent. In the majority of these cancers, the enzyme aromatase (CYP19) is over-expressed. CYP19 is responsible for the biosynthesis of estrogens, which stimulate the proliferation of estrogen-dependent breast cancer cells (Ghosh et al., 2009) . CYP19 is present in a variety of tissues and its gene expression is regulated by different tissue-specific promoters. In normal breast tissue, aromatase is expressed at a low level via the CYP19 promoter I.4. However, in breast cancer, CYP19 promoters PII, I.3 and I.7 become active, whereas they are silent in the healthy mammary gland . There is evidence that exposure to endocrine disruptors may increase the risk of developing hormone-dependent breast cancer via proestrogenic mechanisms (Birnbaum and Fenton, 2003) , although focus has been mainly on estrogen receptor activation (Bouskine et al., 2009; Lemaire et al., 2006) . Effects on aromatase and consequences for human health are less well understood. It has been demonstrated that exposure to atrazine, a widely used herbicide, induces aromatase expression and estrogen biosynthesis in certain human cell lines (Sanderson et al., 2001 (Sanderson et al., , 2002 Thibeault et al., 2014) , but the effects of chemicals on the promoter-and tissue-specific expression of aromatase are largely unknown. In placenta, CYP19 is expressed mainly via the placenta-specific promoter I.1, and the estrogens produced are essential for proper development of placenta and fetus (Albrecht and Pepe, 2010; Bukovsky et al., 2003) .
In this study, we developed quantitative real-time PCR techniques to determine the effects of neonicotinoids on CYP19 gene expression via the breast cancer-relevant promoters PII and I.3, and the pregnancy-relevant placental promoter I.1, using two model human cell lines, adrenocortical carcinoma cells (H295R) and primary umbilical vein endothelial cells (HUVEC).
MATERIALS AND METHODS
Pesticides. All pesticides were obtained from Sigma-Aldrich (Saint-Louis, Missouri) (atrazine Pestanal 45330, purity > 99%; thiacloprid Pestanal 37905 purity > 99%; thiamethoxam Pestanal 37924, purity > 99%; imidacloprid Pestanal 37894, purity > 99%) and were dissolved in dimethylsulfoxide (DMSO) as 100 mM stock solutions.
In vitro models. The H295R cell line was selected for this study since it expresses all enzymes required for steroidogenesis de novo (Gazdar et al., 1990; Hilscherova et al., 2004; Rainey et al., 1994; Sanderson, 2009; Zhang et al., 2005) and the expression of CYP19 in this cell line is regulated by 2 breast cancer-relevant promoters (PII and I.3) , making it a suitable model for the study of CYP19 expression and aromatase activity. It is also approved be the Organization for Economic Cooperation and Development as a tier 1 screening tool for chemically induced disruption of steroidogenesis (OECD, 2011) . HUVEC cells were selected, because they were reported to express CYP19 by its endothelial promoter I.7 (Alvarez-Garcia et al., 2013) and have never been evaluated for additional CYP19 promoter activities. Moreover, HUVEC are primary cells and are more likely to have a realistic regulation of promoter-specific CYP19 expression.
Cell culture. H295R cells (ATCC no. CRL-2128) were obtained from the American Type Culture Collection. H295R cells were cultured in Dulbecco's modified Eagle medium/Ham's F-12 nutrient mix (DMEM/F12) containing 365 mg/ml of L-glutamine. Medium was completed with ITSþ Premix (Fisher Scientific, Waltham, Massachusetts) (final concentration in medium: 6.25 mg/ml insulin; 6.25 mg/ml transferrin; 6.25 ng/ml selenium; 1.25 mg/ml bovine serum albumin; 5.35 mg/ml linoleic acid); and Nu-serum (VWR International, Radnor, Pennsylvania) at a final concentration of 2.5%. Primary HUVEC (ATCC no. PCS-100-010) cells were obtained from the American Type Culture Collection. Primary HUVEC cells were cultured in vascular cell basal medium completed with the endothelial cell growth kit VEGF (ATCC no. PCS-100-041). Complete growth medium contained 5 ng/ml recombinant human (rh) VEGF, 5 ng/ml rh EGF, 5 ng/ml rh-FGF basic, 15 ng/ml rh-IGF-1, 10 mM L-glutamine, 0.75 units/ml heparin sulfate, 1 mg/ml hydrocortisone, 2% fetal bovine serum, and 50 mg/ml ascorbic acid.
Cell viability. The toxicity of atrazine and the neonicotinoids to H295R and HUVEC cells was determined using a WST-1 kit (Roche, Basel, Switzerland) which measures mitochondrial reductase activity of viable cells. H295R and primary HUVEC cells were plated in 96-well plates (5 Â 10 3 cells/well) in their appropriate culture medium for 24 h. After this acclimatization period, cells were exposed to fresh medium containing increasing concentrations of atrazine, thiacloprid, thiamethoxam, or imidacloprid for another 24 h. Cells were then incubated with WST-1 substrate for 1.5 h and the formation of formezan was then measured using the absorbance at 440 nm with SpectraMax M5 spectrophotometer (Molecular Devices, Sunnyvale, California). Each experiment was conducted in triplicate and repeated twice using different cell passages.
are the key to achieving valid results. Therefore, careful consideration was given to the experimental design and qPCR validation. H295R and primary HUVEC cells were cultured in CellBind 6-well plates (Corning Incorporated, Corning, New York) (750 000 cells/well) containing 2 ml medium/well for 24 h. Cells were then exposed for 24 h to the various pesticides. Forskolin (Sigma-Aldrich) was used as a positive control for activation of PII and I.3 promoter-mediated CYP19 gene expression and phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich) for I.1 promoter activation. DMSO vehicle (0.1%) was used as negative control. The 24-h exposure time was selected based on preliminary time-response experiments (0, 12, 24, 48 , and 72 h) using forskolin, PMA, atrazine, and imidacloprid, which demonstrated that maximal (promoter-specific and promoter-indistinct) CYP19 gene expression occurred at 24 h. RNA was isolated using an RNeasy mini-kit (Qiagen, Mississauga, Ontario) according to the enclosed instruction, and stored at À80 C. Purity of the RNA samples was determined using the 260 nm/280 nm absorbance ratio. Reverse transcription was performed using 0.5 mg of RNA with an iScript cDNA Synthesis Kit (BioRad, Hercules, California) and T3000 Thermocycler (Biometra, Gö ttingen, Germany); resultant cDNA was stored at À20 C.
Primer pairs were designed to amplify mRNA species containing an untranslated 5' region uniquely derived from each of the promoters (PII, I.3, I.4, I.1 and I.7) utilized for CYP19 gene expression; a primer pair designed to recognize only the coding region (exons II-X) was used to amplify overall (promoter nondistinct) CYP19 transcript. All the primer pairs were analyzed with Blast and Primer-Blast to ensure that the target sequences were unique to the gene or promoter region in question and that the product length was between 75 and 150 bp (Taylor et al., 2010) . Real-time quantitative PCR was performed using EvaGreen MasterMix (BioRad) with CFX96 real-time PCR Detection System (BioRad) (95 C for 5 min; 40 cycles of 95 C for 5 s and 60 C for 15 s). Standard curves for amplification by each primer pair to ensure an efficiency between 90% and 110% and r 2 value greater than 0.95 (Table 1; only PII, I.3 and I.1 promoter activity was detected in our cell models). Each experiment was conducted in triplicate and repeated twice using different cell passages.
For each pesticide and cell line, two suitable reference genes were included for normalization of CYP19 gene expression (Table 2) . Widely used reference genes such as glyceraldehyde 3-phosphate dehydrogenase (GADPH), 18S or b-actin are not always suitable, since their expression can be highly variable dependent on experimental conditions (Aerts et al., 2004; Radonić et al., 2004) . In our case, it is crucial to evaluate the stability of the expression of different potential reference genes in each cell type and for each treatment. We determined suitable reference genes using the geNorm algorithm method (Biogazelle qbase Plus software, Zwijnaarde, Belgium) to calculate the target stability for each given condition (Taylor et al., 2010) . All reference genes met the criterion for gene expression stability of having an (M) value below 0.5.
Aromatase catalytic activity. Aromatase activity was measured using a tritiated water-release assay as described previously (Lephart and Simpson, 1991; Sanderson et al., 2000) . Briefly, H295R and primary HUVEC cells were cultured in 24-well plates (250 000 or 400 000 cells/well, respectively) containing 1 ml of the appropriate culture medium. After 24 h, cells were exposed to various concentrations of pesticides and incubated for 24 h. The treated medium was then removed and cells were washed twice with 500 ml PBS 1Â. A volume of 250 ml of culture medium (without phenol red) containing 54 nM 1b-3 H-androstenedione was added to each well, and cells were incubated for 90 (H295R) or 150 (HUVEC) minutes at 37 C (5% CO 2 ). Further steps were as described previously (Sanderson et al., 2000) . Tritiated water was counted in 24-well plates containing liquid scintillation cocktail using a Microbeta Trilux (PerkinElmer, Waltham, Massachusetts). Counts per minute produced by each sample were corrected for quenching to determine disintegrations per minute, which were then converted into aromatase activity (fg/h/100 000 cells) and then expressed as a percent of control activity (DMSO). Formestane (1 mM), a selective and irreversible aromatase inhibitor, was used to ensure specificity for the aromatase reaction.
Statistical analysis. Results are presented as means with standard errors of three independent experiments using different cell passages; per experiment, each concentration was tested in triplicate. The normal distribution of the residuals and the homoscedasticity of the data were verified for each analysis using JMP Software (SAS, Cary, North Carolina). Statistically significant differences (*P < .05; **P < .01; ***P < .001) from control were determined by one-way ANOVA followed by a Dunnett 
RESULTS
Effects of Atrazine and Neonicotinoids on Viability of H295R and Primary HUVEC Cells A 24-h exposure to increasing concentrations of atrazine (0.3, 3, 10, 30 mM), imidacloprid (3, 10, 30 mM), thiacloprid, or thiamethoxam (0.1, 0.3, 3, 10, 30 mM) did not statistically affect the viability of H295R (Fig. 1A) or primary HUVEC cells (Fig. 1B) based on mitochondrial reductase activity.
Effects of Atrazine and Neonicotinoids on Promoter-Specific CYP19 Expression in H295R Cells
We determined the effects of a 24-h exposure to atrazine and three neonicotinoids on the PII and I.3 promoter-specific expression of CYP19 in H295R cells. Our positive control forskolin (10 mM) increased PII-and 1.3-derived CYP19 mRNA levels by 11.6 6 2.6 and 13.0 6 3.0-fold, respectively, and promoter-indistinct CYP19 mRNA levels by 3.8 6 0.6 mM. No evidence of I.4 or I.1 promoter activity was found in H295R cells (not shown). Atrazine increased levels of PII and I.3 promoter-derived CYP19 transcript levels in a concentration-dependent manner, resulting in a 6-fold induction at 30 mM ( Fig. 2A ), as has been described previously (Fan et al., 2007; Heneweer et al., 2004) . A 24-h exposure of H295R cells to thiacloprid resulted in a statistically significant increase in relative levels of promoter-indistinct CYP19 mRNA at 0.3 and 10 mM (12.1 -and 2.7-fold, respectively) as well as statistically significant increases in relative levels of PII-and I.3-derived CYP19 transcript (4.6 -and 3.0-fold, respectively) at 0.3 mM (Fig. 2B) . Thiamethoxam at 0.1 mM strongly increased promoter-indistinct CYP19 expression and expression via promoters PII and I.3 (Fig.  2C ) by almost equal extents (between 12.2 -and 15.7-fold). PIIderived mRNA levels were also significantly elevated (2.6-fold) at 0.3 mM (Fig. 2C) . A 24-h exposure to 3 mM imidacloprid caused a statistically significant decrease of about 60 % in the expression of promoter-indistinct CYP19 mRNA levels as well as the levels of PII-and I.3-derived CYP19 transcript (Fig. 2D) .
Effects of Atrazine and Neonicotinoids on Promoter-Specific CYP19 Expression in HUVEC Cells HUVEC cells, which are primary cells of endothelial origin derived from human umbilical cord, were found to express aromatase via the major placental CYP19 promoter I.1. Neither PII, I.3, I.4 nor I.7 CYP19 promoter activity was detected in HUVEC and DMSO control (one-way ANOVA and Dunnett post hoc test; *P < .05; **P < .01; ***P < .001). Experiments were performed in triplicate using different cell passages; per experiment each concentration was tested in triplicate.
cells. We also did not detect endothelial I.7 CYP19 promoter activity in primary HUVEC cells using our qPCR method, neither with published primer pairs that were reported to detect I.7 promoter activity in these cells (Alvarez-Garcia et al., 2013), nor with our own primer designs. On average, PMA induced levels of promoter-indistinct (coding region) CYP19 mRNA by 3.3 6 0.3-fold and levels of I.1 promoter-derived mRNA by 2.5 6 0.3-fold ( Fig. 3A-D) . Atrazine slightly induced the expression of promoter non-distinct CYP19 transcript, with a statistically significant increase of 1.9 6 0.2-fold at 30 mM, but had had no statistically significant effects on I.1 promoter activity (Fig. 3A) . The neonicotinoids did not affect overall or I.1 promotermediated CYP19 expression in HUVEC cells at any tested concentrations ( Fig. 3B-D) .
Effects of Atrazine and Neonicotinoids on CYP19 Catalytic Activity in H295R and HUVEC Cells
To confirm whether the pesticide-induced changes in promoter-specific CYP19 gene expression observed in H295R and primary HUVEC cells resulted in similar changes in catalytic activity of the final enzyme product, we measured the concentration-dependent effects of each pesticide on aromatase activity in each cell type. In H295R cells, forskolin (10 mM) was used as a positive control for induction of CYP19 and increased aromatase activity by 5.3 6 2.2-fold compared to DMSO control, whereas formestane (1 mM), a positive control for inhibition of aromatase activity, reduced activity by about 77%-90% (not shown). In H295R cells, atrazine concentration-dependently induced aromatase activity, increasing it by about 2-fold at 30 mM (Fig. 4A) ; this is consistent with the observed increase in the promoter-specific expression of CYP19 transcript in these cells ( Fig. 2A) . Thiacloprid and thiamethoxam induced aromatase activity statistically significantly at concentrations between 0.1 and 3 mM, producing biphasic concentrationresponse curves, with each pesticide having maximal effect at about 1 mM (Fig. 4A) . Imidacloprid had no effect on aromatase activity in H295R cells within the tested concentration range (Fig. 4A) .
In primary HUVEC cells, PMA (1 mM), a positive control for promoter I.1-controlled induction of CYP19 gene expression, induced aromatase activity, on average, by 2.4 6 0.3-fold compared to DMSO control, whereas formestane (1 mM) inhibited aromatase activity by 80%-100% (not shown). In primary HUVEC cells, atrazine induced aromatase activity concentration-dependently # P < .05). (*, **, ***) A statistically significant difference between pesticide treatment and DMSO control (one-way ANOVA and Dunnett post hoc test; *P < 0.05; **P < 0.01; ***P < 0.001). Experiments were performed in triplicate using different cell passages; per experiment each concentration was tested in triplicate.
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http://toxsci.oxfordjournals.org/ with statistically significant increases at 3 and 30 mM (Fig. 4B) . Neither imidacloprid, thiacloprid nor thiamethoxam induced aromatase activity in a statistically significant manner (Fig. 4B ).
DISCUSSION

Effects of Atrazine and Neonicotinoids on the Promoter-Specific Regulation of CYP19 in H295R Cells
Using atrazine as a positive control, our results confirm that this widely used herbicide is an effective inducer of aromatase via the promoters PII and I.3 in H295R cells. These effects are well documented and consistent with other studies (Fan et al., 2007; Sanderson et al., 2000 Sanderson et al., , 2002 . Atrazine, at concentrations higher than those currently found in the environment, also disrupted ovarian and hypothalamic function in rats, causing altered LH and prolactin synthesis (Cooper et al., 2000) , and induced aromatase expression via a steroidogenic factor-1 (SF-1) dependent pathway in H295R cells (Fan et al., 2007) . At environmentally relevant levels, atrazine exposure reduced growth rates of red drum larvae (Sciaenops ocellatus) exposed to 40 and 80 mg/l for 96 h (del Carmen Alvarez and Fuiman, 2005) . Moreover, a study conducted in Texas coast demonstrated that atrazine levels in runoff water can reach 40-65 mg/l (Pennington et al., 2001) . Therefore, the observed induction of CYP19 expression and activity by atrazine at a concentration as low as 300 nM (H295R cells), lies within an environmentally relevant range.
To our knowledge, we are the first to document the in vitro effects of neonicotinoids on the promoter-specific expression of CYP19 and the catalytic activity of aromatase. In our study, thiacloprid and thiamethoxam strongly induced the expression of PII and I.3 promoter-derived CYP19 mRNA in H295R cells, which is a well-established in vitro model for the study of steroidogenesis (OECD, 2011). The strong increase in expression of total (coding region) CYP19 transcript in H295R cells exposed to 0.3 mM thiacloprid relative to the weaker increase in PII-and I.3-derived transcript levels appears to suggest the presence of other, possibly unknown, aromatase promoters or promoter-independent mechanisms of transactivation in these cells. (We confirmed that neither I.1, I.4 nor I.7 promoter activity was present in H295R cells under our experimental conditions.) Among the neonicotinoids, thiacloprid, and thiamethoxam had the greatest effects on PII and I.3 promoter-specific CYP19 expression in H295R cells. These effects occurred at relatively low concentrations, producing biphasic or non-monotonic concentrationresponse curves. Although an alteration in mRNA expression does not necessarily result in a change in protein expression or enzyme activity, we show that thiacloprid and thiamethoxam altered promoter-specific CYP19 mRNA expression as well as catalytic activity (which we consider a more relevant endpoint in an in vivo context) in a non-monotonic manner. In toxicologically studies of endocrine disrupting chemicals, this type of biphasic response is not uncommon Baldwin, 2001a, 2001b; Kennedy et al., 1993; Giesy et al., 2000; Jobling et al., 2003; Rivest et al., 2011; Sanderson et al., 1998; Vandenberg et al., 2012) . For example, bisphenol A binds the estrogen receptor at low concentrations, but also acts as an antiandrogen at higher ones (Sohoni and Sumpter, 1998) and we have recently shown that androgen receptors are expressed in H295R cells (Robitaille et al., 2015) . This concentration-dependent selectivity of bisphenol A for several hormone receptors was suggested to explain the nonmonotonic shape of the resultant concentration-estrogenic response curve (Vandenberg et al., 2012) . Also, exposure of rats to phtalates leads to a biphasic effect on aromatase activity. This was partially explained by a change in testosterone availability and by the inhibitory action of phtalate metabolites on CYP19 transcript levels (Andrade et al., 2006) . Moreover, Jobling et al. (2003) demonstrated that a 3-week exposure to ethinylestradiol and bisphenol A in prosobrach mollusc (Potamopyrgus antipodarum) stimulated embryo production in an inverted U-shaped dose-response manner, where lower concentrations had a greater effect. Another study conducted on fathead minnow (Pimophales promelas) exposed to 4-nonylphenol (NP) demonstrated an effect of this chemical on egg production and plasma vitellogenin levels, resulting in an inverted U-shape doseresponse curve . It remains unclear how thiacloprid and thiamethoxam produced a non-monotonic response on CYP19 expression and aromatase activity in H295R cells, but it may activate (or deactivate) different intracellular signaling factors that affect CYP19 promoter activity at different concentrations. The action of atrazine on PII/I.3-mediated CYP19 expression occurs by increasing intracellular levels of cAMP (Sanderson et al., 2002) and possibly by interacting with SF-1 (Fan et al., 2007) . It is further known that cAMP-mediated phosphorylation of GATA-4 is involved in SF-1 activation and subsequent stimulation of the CYP19 PII promoter (Tremblay and Viger, 2003) . It is not known whether atrazine activates GATA-4 and it remains to be studied whether thiacloprid and thiamethoxam act as potent inducers via these signaling pathways or by other yet to be delineated mechanisms. Further insight into the mechanisms of induction of CYP19 by neonicotinoids is important in understanding their promoter-specificity and explaining the non-monotonicity of their concentration-response curves. This will be addressed in further studies. Evidence of other adverse or endocrine disruptive effects of neonicotinoids has been observed in recent studies, with imidacloprid inducing apoptosis and fragmentation of seminal DNA in rats (Bal et al., 2012) , and causing oxidative stress and hormone disruption in female rats (Kapoor et al., 2011) . Moreover, a few studies demonstrated that half-lives of certain neonicotinoids, such as imidacloprid, may exceed 1000 days and that around 90% of the active ingredient in neonicotinoid formulations enters the soil (Goulson, 2013) . These characteristics indicate that bioaccumulation of these pesticides may occur and eventually cause subchronic toxicities, which re-enforce the need for toxicological studies of neonicotinoids.
Effects of Atrazine and Neonicotinoids on the Promoter-Specific Regulation of CYP19 in Primary HUVEC Cells We are the first to evaluate the effects of atrazine and neonicotinoids on CYP19 expression and aromatase activity in primary endothelial HUVEC cells. RT-qPCR analyses showed that HUVEC cells express CYP19 (Mukherjee et al., 2002) via the placental PKC-driven I.1 promoter, which is stimulated by the phorbol ester PMA. Atrazine increased promoter non-distinct CYP19 mRNA expression statistically significantly, but this increase in transcript was not derived from the I.1 promoter as its activity remained unchanged (Fig. 3A) . A possible explanation could be the presence of another CYP19 promoter that drives the observed changes in CYP19 expression levels, possibly the endothelium-specific I.7 promoter (Bulun et al., 2003) or an unknown one, although we could not detect any transcript using the currently published sequence for the 5'-untranslated region of I.7 promoter-derived mRNA that was discovered in breast cancer tissues (Sebastian et al., 2002) . Other mechanisms such as inhibition of mRNA degradation could also play a role. The absence of statistically significant effects of the neonicotinoids on aromatase activity in HUVEC cells was consistent with the lack of effects on CYP19 expression at the mRNA level (Figs. 3B-D and 4B). We note that basal aromatase activity in HUVEC cells (2 fmole/h/10 5 cells) is considerably lower than in H295R cells (118 fmole/h/10 5 cells) and less inducible by its positive control PMA (2.4-fold) than by forskolin in H295R cells (5.3-fold). However, given the induction of CYP19 expression and aromatase activity observed with atrazine, endothelial cells (such as HUVEC) should not be ignored as a potential target for endocrine disrupting pesticides and other environmental contaminants. For example, HUVEC cells exposed to environmentally relevant doses of bisphenol A have higher expression of proangiogenic genes such as VEGFR (Andersson and Brittebo, 2012) and exhibit mitotic abnormalities during cell division (Ribeiro-Varandas et al., 2013) .
Relevance of Disruption of Promoter-Specific CYP19 Expression in Health and Disease
The H295R cell line is a useful in vitro model for the study of the effects of chemicals on the PII and I.3 promoter-specific expression of CYP19. The activity of the PII and I.3 promoters of CYP19 are associated with the over-expression of aromatase in the adipose stromal cells surrounding hormone-dependent breast tumors Chen et al., 2009) . The consequence of induction of CYP19 via these two promoters would be an increased local production of estrogens in close proximity to the tumor, increasing the likelihood of cancer cell proliferation. The involvement of the PII promoter in CYP19 over-expression has also been established in ovarian cancer and endometriosis, where the adipose-specific I.4 promoter also appears to be involved (Zeitoun et al., 1999) . Moreover, obesity is associated with higher expression of aromatase in breast fibroblasts via promoters PII/I.3, and women suffering from obesity have greater risk of developing breast cancer (Bulun et al., 2012) . One of the suggested pathways linking obesity with breast cancer and aromatase over-expression is the increased production of prostaglandin E 2 , known to induce aromatase expression via promoters PII and I.3 . Considering the importance of the promoter-specific character of CYP19 expression in various tissues and disease states as well as during pregnancy, our finding that atrazine and certain neonicotinoid pesticides can modulate CYP19 in a promoter-specific manner emphasizes the need for further study of the potential disruptive effects of environmental contaminants on steroidogenesis.
Whether human exposures to environmental contaminants that disrupt CYP19 expression and aromatase activity are sufficiently high to cause or contribute to human disease is an important question that remains to be answered. Atrazine is found in surface waters (Smalling et al., 2015) and in agricultural products (Viden et al., 1987) at concentrations that have been linked to reproductive abnormalities in amphibians (Hayes et al., 2003) and effects on CYP19 expression in the brains of tadpoles of the bullfrog (Rana catesbeiana) (Gunderson et al., 2011) . Furthermore, atrazine is detected in breast milk (Balduini et al., 2003) confirming that infant exposures may occur during a critical developmental period. With regards to the neonicotinoids, levels of clothianidin and thiamethoxam have been steadily increasing since 2012 in water samples from wetlands and agricultural areas in the United States and Canada (concentrations ranging from 0.002 to 3.6 mg/l) (Anderson et al., 2013; Main et al., 2014; Smalling et al., 2015) . Since a large number of studies demonstrate a link between exposures to environmental contaminants and increased risk of breast cancer (Birnbaum and Fenton, 2003; BonefeldJorgensen et al., 2011; Dewailly et al., 1994; Fenton, 2006) or adverse birth outcomes (Rinsky et al., 2012; Vafeiadi et al., 2014) , the increasing use and reliance on chemicals such as pesticides remains a cause of concern.
CONCLUSIONS
We have successfully developed RT-qPCR methods for the quantitative determination of the promoter-specific expression of CYP19. We have shown that the H295R cell line is a useful in vitro model for the study of chemicals that may interfere with the PII and I.3 promoter-specific expression of CYP19 and that primary HUVEC cells express CYP19 via the placenta-type I.1 promoter. To fully understand the promoter-specific regulation of CYP19 in HUVEC or other endothelial cells, further studies would be helpful to assess the activation pathway(s) of the endothelial I.7 promoter. Finally, we are the first to show that neonicotinoid insecticides have the potential to increase the expression of CYP19 in a promoter-specific manner. Given the importance of the promoter-specific expression of CYP19 in breast cancer or during pregnancy, it is important to study how endocrine disrupting chemicals may affect the activity of individual CYP19 promoters in order to better understand and predict the potential risk to exposed women.
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